Infekshanka HCV HCV HCV HCV HCV HCV HSAG iyo SYPHILIsh Combo Combo Combo
Macluumaadka wax soo saarka
| Nambarka moodalka | HBSAG / TP & HIV / HCV | Isku xiris | 20 Imtixaanno / Qalab, 30KITS / CTN |
| Magac | HBSAG / TP & HIV / HCV COMPE TREACK | Kala-saaridda Qalabka | Fasalka III |
| Astaamaha | Dareenka Sare, Applority Fudud | Shahaado | CE / ISO13488 |
| Khalad la'aan | > 97% | Nolosha shelf | Laba sano |
| Hab | Dahab dahab ah | Adeegga OEM / ODM | Aan u uleey |
Xaalad ka sarreeysa
Waqtiga Tijaabada: 15-20mins
Kaydinta: 2-30 ℃ / 36-86 ℉
Habka: Dahabka Cocidal
Muuqaal:
• xasaasiyad sare leh
• Natiijooyinka ka dhasha akhriska 15-20 daqiiqo
• hawlgal fudud
• sax ah
Adeegsiga loogu talagalay
Qalabkan wuxuu ku habboon yahay go'aaminta tayada tacliinta ee cudurka vitroshowga B ee Cagaarshowga B, Syphilis Sorrintochechte, viruska difaaca jirka, iyo hepatitis C faymka 'srum-ka bisil / plas-MA / DHAMMAAN Shaybaarka dhiigga ee ogaanshaha sunta ah ee cagaarshowga B ee Cagaarshowga B, Syphilis Sorringinee, viro-ka tallaalka ee bina-aadamka, iyo infakshanka cagaarshowga C. Natiijooyinka la helay waa inaylagu falanqeeyey iyadoo lala kaashanayo macluumaadka kale ee daryeelka caafimaad. Waxaa loogu talagalay in lagu isticmaalo xirfadlayaal caafimaad oo keliya.
Nidaamka imtixaanka
| 1 | Akhri tilmaamaha siinta iyo is-waafajinta adag ee tilmaamaha loo adeegsado hawlgalka loo baahan yahay si looga fogaado saameynta saxda ah ee natiijooyinka baaritaanka |
| 2 | Imtixaanka ka hor, xirmada iyo muunadda waxaa laga soo saaraa xaalada taxanaha iyo isku dheelitirnaanta heerkulka qolka oo lagu calaamadeeyo. |
| 3 | Baakada baakada Pilouglaha aluminium, qaado qalabka tijaabada oo calaamadee, ka dibna u dhig meel siman miiska baaritaanka. |
| 4 | Cayayaanka Serum / Plasma oo leh dhibic qashin lagu tuuri karo oo ku dar 2 dhibcood oo ka mid ah ceelasha mid kasta iyo S2; Ku dar 3 dhibcood oo ka mid ah ceelasha kasta oo dhan iyo S2 oo ah sanaad oo dhan ka hor inta uusan ku darin 1 ~ 2 dhibcood oo xalka bishimaha ah mid kasta oo ka mid ah ceelka si1 iyo waqtiga ayaa la bilaabaa |
| 5 | Natiijooyinka baaritaanka waa in lagu tarjumaa 15 ~ 20 daqiiqo gudahood, haddii in ka badan 20 daqiiqo natiijooyinka fasiraadda ee la fasiro. |
| 6 | Tarjubaanka muuqaalka waxaa loo isticmaali karaa tarjumaadda natiijada. |
Xusuusin: Muunad kasta waa in lagu tuuraa sicirka la tuuri karo nadiif ah si looga fogaado in laga gudbo faddaraynta.
Waxqabadka rugta caafimaad
| Natiijooyinka WizOr
| Tijaabada Tijaabada tixraac Reagent | Heerka wanaagsan ee isku-dhafka ah: 99.06% (95% CI 96.64% ~ 99.74%) Heerka ugu xun: 98.69% (95% CI96.68% ~ 99.49%) Isugeynta heerka isku-darka: 98.84% (95% cI97.50% ~ 99.47% | ||
| Xaqiiq ah | Diidmo ah | Wadar ah | ||
| Soo jiidasho | 211 | 4 | 215 | |
| Diidmo ah | 2 | 301 | 303 | |
| Wadar ah | 213 | 305 | 518 | |
| Natiijooyinka WizTP
| Tijaabada Tijaabada tixraac Reagent | Heerka wanaagsan ee isku-dhafka ah: 96.18% (95% CI 91.38% ~ 98.36%) Heerka yaabka xun: 97.67% (95% CI95.64% ~ 98.77%) Wadarta heerka isku-darka: 97.30% (95% CI95.51% ~ 98.38%) | ||
| Xaqiiq ah | Diidmo ah | Wadar ah | ||
| Soo jiidasho | 126 | 9 | 135 | |
| Diidmo ah | 5 | 378 | 383 | |
| Wadar ah | 131 | 387 | 518 | |
| Natiijooyinka WizEe hcv
| Tijaabada Tijaabada tixraac Reagent | Heerka wanaagsan ee isku dhafka ah: 93.44% (95% CI 84.32% ~ 97.42%) Heerka ugu xun: 99.56% (95% CII98.42% ~ 99.88%) Isugeynta heerka isku-darka: 98.84% (95% CI97.50% ~ 99.47%) | ||
| Xaqiiq ah | Diidmo ah | Wadar ah | ||
| Soo jiidasho | 57 | 2 | 59 | |
| Diidmo ah | 4 | 455 | 459 | |
| Wadar ah | 61 | 457 | 518 | |
| Natiijooyinka WizEe HIV
| Tijaabada Tijaabada tixraac Reagent | Heerka wanaagsan ee isku-dhafka ah: 96.81% (95% CI 91.03% ~ 98.91%) Heerka ugu xun: 99.76% (95% CII98.68% ~ 99.96%) Wadarta heerka isku-darka: 99.23% (95% CI98.03% ~ 99.70%) | ||
| Xaqiiq ah | Diidmo ah | Wadar ah | ||
| Soo jiidasho | 91 | 1 | 92 | |
| Diidmo ah | 3 | 423 | 446 | |
| Wadar ah | 94 | 424 | 518 | |
